Mnemonic for the Diagnosis of Hypomania Associated with Bipolar II Disorder

Entsuah AR Huang H Thase ME . Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo. J Clin Psychiatry 2001;62:869–77.

Thase ME Entsuah AR Rudolph RL . Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001;178:234–41.

Henry C Sorbara F Lacoste J Gindre C Leboyer M. Antidepressant induced mania in bipolar patients: Identification of risk factors. J Clin Psychiatry 2001;62:249–55.

Akiskal HS Maliya G. Criteria for the “soft” bipolar spectrum: Treatment implications. Psychopharmacol Bull 1987;23:68–73.

Akiskal HS Burgeois ML Angst J Post R Moller HJ Hirschfield R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 2000;59(suppl 1):S5–S30.

Manning JS Haykal RF Connor PD Akiskal HS . On the nature of depressive and anxious states in a family practice setting: The high prevalence of bipolar II and related disorders in a cohort followed longitudinally. Compr Psychiatry 1997;38:102–8.

Dunner DL Tay LK . Diagnostic reliability of the history of hypomania in bipolar II patients and patients with major depression. Compr Psychiatry 1993;34:303–7.

Hirschfield RM Keller MB Panico S Arons BS Barlow D Davidoff F , and others. The National Depressive and Manic–Depressive Association consensus statement on the undertreatment of depression. JAMA 1997;277:333–40.

Living with bipolar disorder: How far have we really come? Constituency Survey of the National Depressive and Manic–Depressive Association. Chicago (IL). National Depressive and Manic–Depressive Association; 2002.